DrugBaron

FEBRUARY 7, 2022

Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. Yet the situation with small molecules is even worse.

Small Molecule 100

Small Molecule Synthetic Chemistry Pharma Companies Pharmacokinetics 100

The Strateos Blog: Drug Discovery

SEPTEMBER 24, 2021

On September 15th, Strateos hosted Part 2 of its Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis. Ben Miles, Ph.D., Head of Product Management at Strateos was joined by Josh Bond, Director of Product Management at PerkinElmer Informatics to discuss this exciting collaboration. Ben Miles, Ph.D.,

Synthetic Chemistry 52

Synthetic Chemistry Small Molecule Production Science 52

Dark Matter Blog

APRIL 8, 2020

Our Chinese CROs are back online and doing synthetic chemistry at a pre-pandemic pace. Our ambition was to unlock vast swaths of valuable biology inaccessible to medicine today because the proteins involved elude our reach. The good news is that plenty of work can continue even with our own lab dormant.

RNA 52

RNA Small Molecule Synthetic Chemistry Science 52

The Pharma Data

DECEMBER 4, 2021

Pfizer scientists will also collaborate with AWS healthcare and life sciences professionals to explore how researchers in Pfizer’s Pharmaceutical Sciences Small Molecules teams can extract and mine information from legacy documents by leveraging AWS analytics and machine learning services.

Drug Development 52

Drug Development Small Molecule Synthetic Chemistry Drugs 52

The Strateos Blog: Drug Discovery

AUGUST 16, 2021

Director of Chemistry of Strateos gave an interactive talk focused on how automated robotics and integrated software are powering self-driving labs that are revolutionizing synthetic chemistry to support medicinal chemistry workflows. Director of R&D Strategy and Vince Yeh, Ph.D.,

Synthetic Chemistry 52

Synthetic Chemistry Small Molecule Drugs Clinical Trials 52

The Strateos Blog: Drug Discovery

FEBRUARY 22, 2022

Strateos’ SVP of Strategy and Operations, Daniel Sipes, gave a presentation outlining how the challenges in conventional design, make, test and analyze (DMTA) cycles in small molecule drug discovery workflows can be overcome with automated end-to-end solutions from synthesis to biological testing.

Small Molecule 52

Small Molecule Science Laboratories Production 52